4D-Nucleofector®️ LV Unit: Efficient, non-viral large-scale transfection for cell and gene therapy applications

Published: 13 December 2021
Timo Gleissner,
Andrea Toell

Watch the video or read the poster to learn:

  • A brief introduction to the 4D-Nucleofector®️ LV Unit and its consumables
  • Tips and tricks on how to use the system
  • Use of the system in a GMP manufacturing process

Timo Gleissner is Associate Director Engineering within Bioscience Solutions at Lonza Cologne GmbH and responsible for the technical development of Lonza’s Nucleofector®️ Transfection Platforms. In his current role Timo lead the development of the 4D-Nucleofector®️ LV Unit for large-scale transfection and had the technical responsibility for the product design of the 21CFR part 11 compliant software as well as the TheraPEAK®️ Consumables for GMP manufacturing.

Andrea Toell is a Senior Product Manager at Lonza Cologne GmbH and is responsible for Lonza’s Nucleofector®️ Transfection Portfolio. In her current role she is focusing on large volume transfection and cell and gene therapy applications (CAR-T cells, genome editing, GMP manufacturing). In her 20 years’ experience with the technology she gained a broad knowledge about transfection technologies and factors that are important for successful transfection experiments.

Read now